Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: Re: Stockhouse ad/article
48
Jan 05, 2023 09:18AM
32
Jan 05, 2023 10:11AM
15
Jan 05, 2023 10:15AM
10
Jan 05, 2023 10:36AM
15
Jan 05, 2023 10:36AM
11
Jan 05, 2023 10:38AM
17
Jan 05, 2023 11:24AM
26
Jan 05, 2023 11:59AM
31
Jan 05, 2023 12:02PM

Jan 05, 2023 12:48PM
1
Jan 05, 2023 01:00PM
5
Jan 05, 2023 04:13PM

Well ARKK has about 30 holdings, the smallest of which is FATE Therapeutics at a market value of $600k at 0.01% of the fund's weight. Just below NVDA with $5.3M and making up 0.09% of the weight. 

https://ark-funds.com/funds/arkk/

 

PRNT on the other hand contains about 50 companies. Includes such gems as PYRogenesis at $210k at 0.09%, just below Xerox at $201k and 0.11%. 

 

https://ark-funds.com/funds/prnt/

 

Despite the absolutely miserable performances of both funds, it would be a dream to have some consistent and sustained buying of such a fund. 

14
Jan 05, 2023 04:30PM
5
Jan 05, 2023 07:39PM
9
Jan 05, 2023 07:40PM
3
Jan 07, 2023 07:45AM
Share
New Message
Please login to post a reply